Ipca
Laboratories shares hit fresh 52-week low of Rs 480 on Friday, falling 14
percent intraday after Geneva-based fund decided not to source any anti-malaria
drug from the company.
At 09:29 hours IST, the scrip of Ipca Laboratories was quoting at Rs 502.20, down Rs 56.35, or 10.09 percent amid high volumes on the BSE.
At 09:29 hours IST, the scrip of Ipca Laboratories was quoting at Rs 502.20, down Rs 56.35, or 10.09 percent amid high volumes on the BSE.
Meet me at www.marketmagnify.com/stock-cash-power.php
A proper advices and recommendations from Epic Research to traders make huge difference in their profits. Use free Commodity tips from them and experience of it.
ReplyDelete